Treatment of HBV/HCV coinfection

Author： Potthoff Andrej   Manns Michael P   Wedemeyer Heiner  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.6, 2010-04, pp. : 919-928

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Treatment of HIV/HBV and HIV/HCV Co-Infection

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 9, 2012-08 ,pp. : 890-904

Bentham Science Publishers

Access to resources Recommend Favorite

Patents and development of HBV and HCV clinical treatment: from 2001 to April 2005

By Chen Zhi   Zheng Min  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 8, 2005-08 ,pp. : 1027-1039

Informa Healthcare

Access to resources Recommend Favorite

Resistance of HBV and HCV to antiviral therapies

By Polyak Stephen J  

Future Virology, Vol. 3, Iss. 3, 2008-05 ,pp. : 221-224

Future Medicine

Access to resources Recommend Favorite

Nevirapine hastens liver fibrosis in HIV/HCV coinfection

By  

Reactions Weekly, Vol. 1, Iss. 1007, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Molecular diagnosis of occult HCV and HBV infections

By Michalak Tomasz I   Pham Tram NQ   Mulrooney-Cousins Patricia M  

Future Virology, Vol. 2, Iss. 5, 2007-09 ,pp. : 451-465

Future Medicine

Access to resources Recommend Favorite